Janux Therapeutics: Q1 Earnings Insights

Janux Therapeutics JANX reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.


Janux Therapeutics beat estimated earnings by 14.29%, reporting an EPS of $-0.42 versus an estimate of $-0.49.

Revenue was up $459 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.1 which was followed by a 0.18% drop in the share price the next day.

Here's a look at Janux Therapeutics's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.49 -0.49 -0.37 -0.37
EPS Actual -0.39 -0.40 -0.41 -0.32
Revenue Estimate 790K 740K 850K 820K
Revenue Actual 2.85M 1.81M 2.37M 1.59M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Janux Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.


Analyst Ratings




Posted In: EarningsBZI-Recaps